| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells
|
Wang, Mingjin
|
|
|
13 |
12 |
p. 4733-4747
|
artikel
|
| 2 |
ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17
|
Zhang, Junting
|
|
|
13 |
12 |
p. 4840-4855
|
artikel
|
| 3 |
An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma
|
Qiu, Qiujun
|
|
|
13 |
12 |
p. 5091-5106
|
artikel
|
| 4 |
A unique binding pocket induced by a noncanonical SAH mimic to develop potent and selective PRMT inhibitors
|
Deng, Youchao
|
|
|
13 |
12 |
p. 4893-4905
|
artikel
|
| 5 |
Converting bacteria into autologous tumor vaccine via surface biomineralization of calcium carbonate for enhanced immunotherapy
|
Guo, Lina
|
|
|
13 |
12 |
p. 5074-5090
|
artikel
|
| 6 |
Cover Story
|
|
|
|
13 |
12 |
p. xii
|
artikel
|
| 7 |
Development of exosome membrane materials-fused microbubbles for enhanced stability and efficient drug delivery of ultrasound contrast agent
|
Jang, Yongho
|
|
|
13 |
12 |
p. 4983-4998
|
artikel
|
| 8 |
Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection
|
Zhao, Xintong
|
|
|
13 |
12 |
p. 4945-4962
|
artikel
|
| 9 |
Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer
|
Huang, Jia-Luo
|
|
|
13 |
12 |
p. 4934-4944
|
artikel
|
| 10 |
Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
|
Wang, Yubo
|
|
|
13 |
12 |
p. 4963-4982
|
artikel
|
| 11 |
Emerging drug design strategies in anti-influenza drug discovery
|
Liu, Chuanfeng
|
|
|
13 |
12 |
p. 4715-4732
|
artikel
|
| 12 |
Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner
|
Zhang, Kaikai
|
|
|
13 |
12 |
p. 4801-4822
|
artikel
|
| 13 |
Hippo pathway-manipulating neutrophil-mimic hybrid nanoparticles for cardiac ischemic injury via modulation of local immunity and cardiac regeneration
|
Wang, Qiaozi
|
|
|
13 |
12 |
p. 4999-5015
|
artikel
|
| 14 |
Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSVMT) in golden syrian hamster
|
Ke, Yong
|
|
|
13 |
12 |
p. 4856-4874
|
artikel
|
| 15 |
Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming
|
Duan, Shixin
|
|
|
13 |
12 |
p. 4785-4800
|
artikel
|
| 16 |
Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment
|
Zhang, Yan
|
|
|
13 |
12 |
p. 5107-5120
|
artikel
|
| 17 |
Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy
|
Liu, Xiaodi
|
|
|
13 |
12 |
p. 5048-5059
|
artikel
|
| 18 |
Non-canonical STING–PERK pathway dependent epigenetic regulation of vascular endothelial dysfunction via integrating IRF3 and NF-κB in inflammatory response
|
Li, Xuesong
|
|
|
13 |
12 |
p. 4765-4784
|
artikel
|
| 19 |
Orange-derived extracellular vesicles nanodrugs for efficient treatment of ovarian cancer assisted by transcytosis effect
|
Long, Feng
|
|
|
13 |
12 |
p. 5121-5134
|
artikel
|
| 20 |
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain barrier and exhibits potent activity against glioblastoma
|
Liu, Yingqiang
|
|
|
13 |
12 |
p. 4748-4764
|
artikel
|
| 21 |
Purpurolide C-based microneedle promotes macrophage-mediated diabetic wound healing via inhibiting TLR4-MD2 dimerization and MYD88 phosphorylation
|
Liu, Yitong
|
|
|
13 |
12 |
p. 5060-5073
|
artikel
|
| 22 |
Reactive oxygen species and nitric oxide scavenging nanoparticles alleviating rheumatoid arthritis through adjusting the seeds and growing soils
|
Hua, Peng
|
|
|
13 |
12 |
p. 5016-5029
|
artikel
|
| 23 |
Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity
|
Jing, Huaqing
|
|
|
13 |
12 |
p. 5030-5047
|
artikel
|
| 24 |
Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis
|
Yu, Wenjing
|
|
|
13 |
12 |
p. 4875-4892
|
artikel
|
| 25 |
Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility
|
Zhao, Li-Min
|
|
|
13 |
12 |
p. 4906-4917
|
artikel
|
| 26 |
Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors
|
Fang, Feifei
|
|
|
13 |
12 |
p. 4918-4933
|
artikel
|
| 27 |
Table of Contents
|
|
|
|
13 |
12 |
p. iii-xii
|
artikel
|
| 28 |
Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy
|
Ye, Jing
|
|
|
13 |
12 |
p. 4688-4714
|
artikel
|
| 29 |
Targeting the blood–brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays
|
Wang, Yanping
|
|
|
13 |
12 |
p. 4667-4687
|
artikel
|
| 30 |
TBC1D15 deficiency protects against doxorubicin cardiotoxicity via inhibiting DNA-PKcs cytosolic retention and DNA damage
|
Yu, Wenjun
|
|
|
13 |
12 |
p. 4823-4839
|
artikel
|
Tijdschrift beschrijving